New
HealthMore in Health→
NOAC Blood Thinners May Slow Cognitive Decline in Alzheimer's Patients with Atrial Fibrillation
Key Takeaways
- Study from Karolinska Institutet published in European Heart Journal.
- Included 7,308 patients with both atrial fibrillation and Alzheimer's disease.
- Patients on NOACs showed slower cognitive decline than those on warfarin or no anticoagulants.
- Difference was about 0.2 MMSE points per year.
DE
DT Editorial Team··via medicalxpress.com